Join
Live feed
·
INSIDERFilingvia Quantisnow
Acrivon Therapeutics Inc. logo

Chief Legal Officer Miller Mary sold $372 worth of shares (185 units at $2.01), decreasing direct ownership by 0.23% to 82,009 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRV (Acrivon Therapeutics Inc.) and more on Quantisnow.